Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
16 Cards in this Set
- Front
- Back
Somatotropin
|
Growth Hormone Analog
Mechanism of Action:*Single GH molecule dimerizes 2 surface JAK/STAT cytokine receptors --> ↑ IGF-1 which mediates growth stimulating effects Adverse reaction:*Children --> less adverse effects than adults, hypothyroidism, pancreatitis, gynecomastia, nevus growth, intracranial hypertension *Adults --> peripheral edema, myalgias, arthralgias, carpal tunnel syndrome, ↑ P450 *Contraindicated in malignancy Clinical Use:*Growth failure in children --> GH deficiency, Praderwilli syndrome, Turner Syndrome, Chronic renal failure, idiopathic short stature *Patient with AIDS *Short bowel syndrome |
|
Somatrem
|
Growth Hormone Analog
Mechanism of Action:*Single GH molecule dimerizes 2 surface JAK/STAT cytokine receptors --> ↑ IGF-1 which mediates growth stimulating effects Adverse reaction:*Children --> less adverse effects than adults, hypothyroidism, pancreatitis, gynecomastia, nevus growth, intracranial hypertension *Adults --> peripheral edema, myalgias, arthralgias, carpal tunnel syndrome, ↑ P450 *Contraindicated in malignancy Clinical Use:*Growth failure in children --> GH deficiency, Praderwilli syndrome, Turner Syndrome, Chronic renal failure, idiopathic short stature *Patient with AIDS *Short bowel syndrome |
|
Octreotide
|
Growth Hormone Antagonist
Mechanism of action:*Binds to SSTR2 and SSTR5 receptors --> ↓ adenylate cyclase and cAMP --> ↓ GH release *Somatostatin analog 45X more potent than somatatostatin in inhibiting GH release *2X more potent than somatostatin in reducing insulin secretion Adverse Reaction:*nausea, vomiting, abdominal pain *sinus bradycardia *gallstones (↓ gall bladder contraction and GI transit time) Clinical Use:*GH excess |
|
Bromocriptine
|
Prolactin Antagonist
Mechanism of action:*D2 receptor agonists --> ↓ prolactin secretion from anterior pituitary *small tumor --> therapy discontinued during pregnancy *Large tumor --> therapy continued throughout pregnancy Adverse Reaction:*orthostatic hypotension, fatigue Clinical Use:*Hyperprolactenemia *Parkinson’s *Acromegaly |
|
Pergolide
|
Prolactin Antagonist
Mechanism of action:*D2 receptor agonists --> ↓ prolactin secretion from anterior pituitary *small tumor --> therapy discontinued during pregnancy *Large tumor --> therapy continued throughout pregnancy Adverse Reaction:*orthostatic hypotension, fatigue Clinical Use:*Hyperprolactenemia *Parkinson’s *Acromegaly |
|
Follitropin
|
FSH Analog
Mechanism of action:*Recombinant FSH Adverse Reaction:*Multiple birth *gynecomastia *Ovarian hyperstimulation syndrome --> Ovarian enlargement, hemoperitoneum from ruptured ovarian cyst, Hypovolemia, Electrolyte abnormaities, Thromboembolic events, Hepatic dysfunction, Abdominal pain, ARDS Clinical Use:*anovulation caused by hypogonadotropic hypogonadism and polycystic ovary syndrome *Male infertility |
|
Lutropin
|
LH Analog
Mechanism of action:*Recombinant LH used only in combination with follitropin alpha Adverse Reaction:*Multiple birth *gynecomastia *Ovarian hyperstimulation syndrome --> Ovarian enlargement, hemoperitoneum from ruptured ovarian cyst, Hypovolemia, Electrolyte abnormaities, Thromboembolic events, Hepatic dysfunction, Abdominal pain, ARDS Clinical Use:*anovulation caused by hypogonadotropic hypogonadism and polycystic ovary syndrome *Male infertility |
|
hCG
|
LH Analog
Mechanism of action: LH analog Adverse Reaction:*Multiple birth *gynecomastia *Ovarian hyperstimulation syndrome --> Ovarian enlargement, hemoperitoneum from ruptured ovarian cyst, Hypovolemia, Electrolyte abnormaities, Thromboembolic events, Hepatic dysfunction, Abdominal pain, ARDS Clinical Use:*anovulation caused by hypogonadotropic hypogonadism and polycystic ovary syndrome *Male infertility |
|
Gonadorelin
|
Synthetic Gonadotropin-releasing hormone
Mechanism of action:*Pulsatile GnRH secretion --> stimulates release of FSH and LH *Sustained, non-pulsatiles administration of GnRH inhibits release of gonadotropin Adverse Reaction:*Menopause *Ovarian cysts *osteoporosis *Headache,dizziness, nausea Clinical Use:*Treatment of infertinilty (Pulsatile administration) --> precipitate LH surge and ovulation in infertile women undergoing ovulation induction with gonadotropins *Infertility in men with hypothalamic-hypogonadotropic hypogonatism *Suppression of gonadotropin release (Non-pulsatiles administration) --> 1.Hormonally responsive tumor:prostate, breast and ovarian cancer. 2.Endometriosis: use less than 6 months to protect bone density 3.Uterine leiomyomata (uterine fibroids) 4.Central precious puberty 5. Controlled ovarian hyperstimulation |
|
Goserelin
|
Gonadotropin-releasing hormone analog
Mechanism of action:*Pulsatile GnRH secretion --> stimulates release of FSH and LH *Sustained, non-pulsatiles administration of GnRH inhibits release of gonadotropin Adverse Reaction:*Menopause *Ovarian cysts *osteoporosis *Headache,dizziness, nausea Clinical Use:*Treatment of infertinilty (Pulsatile administration) --> precipitate LH surge and ovulation in infertile women undergoing ovulation induction with gonadotropins *Infertility in men with hypothalamic-hypogonadotropic hypogonatism *Suppression of gonadotropin release (Non-pulsatiles administration) --> 1.Hormonally responsive tumor:prostate, breast and ovarian cancer. 2.Endometriosis: use less than 6 months to protect bone density 3.Uterine leiomyomata (uterine fibroids) 4.Central precious puberty 5. Controlled ovarian hyperstimulation |
|
Leuprolide
|
Gonadotropin-releasing hormone analog
Mechanism of action:*Pulsatile GnRH secretion --> stimulates release of FSH and LH *Sustained, non-pulsatiles administration of GnRH inhibits release of gonadotropin Adverse Reaction:*Menopause *Ovarian cysts *osteoporosis *Headache,dizziness, nausea Clinical Use:*Treatment of infertinilty (Pulsatile administration) --> precipitate LH surge and ovulation in infertile women undergoing ovulation induction with gonadotropins *Infertility in men with hypothalamic-hypogonadotropic hypogonatism *Suppression of gonadotropin release (Non-pulsatiles administration) --> 1.Hormonally responsive tumor:prostate, breast and ovarian cancer. 2.Endometriosis: use less than 6 months to protect bone density 3.Uterine leiomyomata (uterine fibroids) 4.Central precious puberty 5. Controlled ovarian hyperstimulation |
|
Cetrorelix
|
Gonadotropin-releasing hormone antagonist
Mechanism of action:*GnRH antagonist *Advantages over GnRH agonist --> immediate effect, shorter duration, lower risk of Ovarian hyperstimulation syndrome Adverse Reaction: Clinical Use:*Prevent LH surge during controlled ovarian hyperstimulation |
|
Ganirelix
|
Gonadotropin-releasing hormone antagonist
Mechanism of action:*GnRH antagonist *Advantages over GnRH agonist --> immediate effect, shorter duration, lower risk of Ovarian hyperstimulation syndrome Adverse Reaction: Clinical Use:*Prevent LH surge during controlled ovarian hyperstimulation |
|
Oxytocin
|
Mechanism of action:*Stimulates uterine contraction via Gq receptor pathway --> activates PCL-IP3-Ca -->↑ local prostaglandin production
Adverse Reaction:*uncommon *Excessive stimulation of uterus --> uterine rupture, placenta abruption, fetal death *activation of ADH receptors --> hypertensive crisis and H20 retention Clinical Use:*Induce labor *Control post-partum uterine bleeding |
|
Desmopressin
|
Mechanism of action:*Long-lasting ADH analogy 4000X greater antidiuretic/pressor ratio --> Binds V2 >>>> V1
Adverse Reaction:*H20 intoxication *hyponatremia Clinical Use:*Central diabetes insipidus *nocturnal enuresis *coagulopathy in hemophilia A and von Willebrand’s disease |
|
Vasopressin
|
Mechanism of action:*Binds V1receptor --> vasoconstriction *Bind V2 receptor --> water resorption in collecting tubules
Adverse Reaction:* H20 intoxication *hyponatremia *seizures *Caution in CAD patients Clinical Use:*3rd line drugs for shock *Bleeding due to esophageal varices or colonic diverticula |